Immunosurveillance and therapy of multiple myeloma are CD226 dependent-Reference-Cited by-同舟云学术

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Published:2015-04-20 Issue:5 Volume:125 Page:2077-2089
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Guillerey Camille,Ferrari de Andrade Lucas,Vuckovic Slavica,Miles Kim,Ngiow Shin Foong,Yong Michelle C.R.,Teng Michele W.L.,Colonna Marco,Ritchie David S.,Chesi Martha,Bergsagel P. Leif,Hill Geoffrey R.,Smyth Mark J.,Martinet Ludovic

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference73 articles.

1. Multiple Myeloma

2. Molecular pathogenesis of multiple myeloma and its premalignant precursor

3. Long-Term Analysis of the IFM 99 Trials for Myeloma: Cytogenetic Abnormalities [t(4;14), del(17p), 1q gains] Play a Major Role in Defining Long-Term Survival

4. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

5. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications;Frontiers in Immunology;2024-09-03

2. Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints;Science Advances;2024-08-30

3. Next-Generation Therapies for Multiple Myeloma;Annual Review of Cancer Biology;2024-06-12

4. Immune-Pathogenesis of Myeloma;Hematology/Oncology Clinics of North America;2024-04

5. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma;Immunogenetics;2024-03-13